Erytech Pharma SA operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £3.14 million [US$4.08 million]
of which 48%
(5.70 million Euro [US$6.42 million]
(6.44 million Euro [US$7.25 million]
During the year ended December of 2018, sales at
Erytech Pharma SA were 4.45 million Euro (US$5.01 million).
increase of 32.2%
versus 2017, when the company's sales were 3.36 million Euro.